Carole S. Ben-Maimon is a businessperson who founded Alita Pharmaceuticals, Inc. and who has been at the head of 9 different companies.
She is President, Chief Executive Officer & Director at Larimar Therapeutics, Inc. and President, Chief Executive Officer & Director at Chondrial Therapeutics Holdings LLC (a subsidiary of Larimar Therapeutics, Inc.).
She is also on the board of Teligent, Inc., Bionpharma, Inc. (former Chairman) and Albert Einstein Healthcare Network.
In the past Dr. Ben-Maimon was President, Chief Executive Officer & Director at Alita Pharmaceuticals, Inc., President & Chief Operating Officer at Teva Branded Pharmaceutical Products R&D, Inc., Vice President-Medical & Regulatory Affairs at Lemmon Co., President, Chief Executive Officer & Director at Chondrial Therapeutics, Inc., President & Director at Barr Pharmaceuticals, Inc., President at Global Pharmaceuticals Cos LLC, Senior Vice President-Science & Public Policy at Teva Pharmaceuticals USA, Inc., President-Generic Products at Impax Laboratories LLC, Secretary & Senior VP-Corporate Strategy at Brenn Distribution, Inc. and Chairman of Association for Accessible Medicines.
She received an undergraduate degree from Thomas Jefferson University, an undergraduate degree from the University of Pennsylvania and a doctorate from Sidney Kimmel Medical College.